APOE4 -dependent phenotypes—including lipid dysregulation, impaired Aβ clearance, and increased neuroinflammation—are consistently observed in AD organoids, providing a translationally relevant platform for testing neuroprotective compounds, anti-Aβ antibodies, anti-tau agents, or modulators of lipid metabolism [93]. Here, MAPT is linked to Alzheimer disease.